Basic information Safety Supplier Related

Bendamustine

Basic information Safety Supplier Related

Bendamustine Basic information

Product Name:
Bendamustine
Synonyms:
  • 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
  • 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
  • Bendamustine
  • -1-methyl-1H-benzo[d]imidazol-2-yl)
  • 4-(5-(Bis(2-chloroethyl)
  • 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
  • 4-(5-(bis(2-chloroethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoic acid
  • 1H-BenziMidazole-2-butanoicacid, 5-[bis(2-chloroethyl)aMino]-1-Methyl-
CAS:
16506-27-7
MF:
C16H21Cl2N3O2
MW:
358.26
Mol File:
16506-27-7.mol
More
Less

Bendamustine Chemical Properties

Boiling point:
585.2±50.0 °C(Predicted)
Density 
1.31±0.1 g/cm3(Predicted)
storage temp. 
-20°C, protect from light
solubility 
DMSO : 100 mg/mL (279.13 mM; Need ultrasonic)
pka
4.50±0.10(Predicted)
form 
Solid
color 
White to off-white
InChI
InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)
InChIKey
YTKUWDBFDASYHO-UHFFFAOYSA-N
SMILES
C1(CCCC(O)=O)N(C)C2=CC=C(N(CCCl)CCCl)C=C2N=1
More
Less

Safety Information

Hazardous Substances Data
16506-27-7(Hazardous Substances Data)
More
Less

Bendamustine Usage And Synthesis

Uses

Treatment of hematologic cancer, especially non-Hodgkin’s lymphoma.

Definition

ChEBI: Bendamustine is a member of benzimidazoles.

brand name

Ribomustine (Amcis AG, Switzerland).

in vivo

Bendamustine (25 mg/kg, i.v.) shows potent inhibition on the growth of tumor cells by 91%, 99% and 95% for DoHH-2, Granta 519 and RAMOS models, respectively. Moreover, the antitumor effect of Bendamustine is enhanced by rituximab in DoHH-2 and RAMOS models, but not in Granta 519 model[3].

Enzyme inhibitor

This nitrogen mustard and anticancer drug (FWfree-acid = 358.26 g/mol; CAS 16506-27-7), also known by its code name SDX-105, its trade names Treanda?, Treakisym?, Ribomustin?, and Levact?, as well as by its systematic name 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2- yl]butanoic acid, is a relatively nonspecific DNA alkylating agent that causes intra- and inter-strand cross-links. Bendamustine is used in the treatment of chronic lymphocytic leukemia (CLL), Hodgkin’s disease, nonHodgkin’s lymphoma, multiple myeloma and lung cancer. Pharmacokinetics: After intravenous infusion, >95% of the drug becomes protein-bound, mainly to albumin; however, only free bendamustine is active. Bendamustine is metabolized by liver cytochrome p450, and elimination (renal) is biphasic, with an initial half-life of 6–10 minutes and a terminal half-life of approximately 30 minutes.

BendamustineSupplier

Chengdu Saint - Kay Biotechnology Co., Ltd. Gold
Tel
028-85157043 15882256948
Email
676046971@qq.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com
Shanghai Longsheng chemical Co.,Ltd.
Tel
021-58099652-8005 13585536065
Email
bin.wu@shlschem.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn